Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
Why this paper is included
Supporting source evidence:
Transgenic AZ‐GR, IZ‐VDRE, PZ‐TR, AIZ‐AR, and PAZ‐PPARγ cells were incubated with tested compounds and the model ligands, i.e., dexamethasone (DEX, 100 nM), calcitriol (1α,25‐VD3, 50 nM), 3,5,3′‐triiodothyronine (T3, 10 nM), dihydrotestosterone (DHT, 100 nM), and 15‐deoxy‐δ12,14‐prostaglandin J2 (15d‐PGJ2; 40 μM), respectively. (A) Glucocorticoid receptor; (B) vitamin D receptor; (C) thyroid receptor; (D) androgen receptor; and (H) peroxisome proliferator‐activated receptor gamma (PPARγ). (A: D) The histogram depicts mean ± SD from experiments performed in two consecutive passages of cells. (H), Histogram depicts mean ± SD from one of two independent experiments each performed in triplicate. *P < 0.05, two‐way ANOVA. (E) Human constitutive androstane receptor (hCAR) reporter activity in HEK293T cells.
Source: Characterization of FKK compounds as hPXR, AhR (aryl hydrocarbon receptor), and dual hPXR/AhR agonists. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Study design awaiting verification.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.
Meta-analysis unclear · Blinding unclear / not reported · Mixed research settings
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
LS174T cells were initially purchased from ATCC, and before use, cell line authenticity was validated as previously described (Wang et al, ).
Source: Methods.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Targeting the pregnane X receptor using microbial metabolite mimicry
Study design awaiting verification · EMBO Molecular Medicine · 2020
Original publication title
Targeting the pregnane X receptor using microbial metabolite mimicry
© 2020 The Authors. Published under the terms of the CC BY 4.0 license
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
What does the authors’ abstract report?
Abstract
The human PXR (pregnane X receptor), a master regulator of drug metabolism, has essential roles in intestinal homeostasis and abrogating inflammation. Existing PXR ligands have substantial off‐target toxicity. Based on prior work that established microbial (indole) metabolites as PXR ligands, we proposed microbial metabolite mimicry as a novel strategy for drug discovery that allows exploiting previously unexplored parts of chemical space. Here, we report functionalized indole derivatives as first‐in‐class non‐cytotoxic PXR agonists as a proof of concept for microbial metabolite mimicry.
The lead compound, FKK6 (Felix Kopp Kortagere 6), binds directly to PXR protein in solution, induces PXR‐specific target gene expression in cells, human organoids, and mice. FKK6 significantly represses pro‐inflammatory cytokine production cells and abrogates inflammation in mice expressing the human PXR gene. The development of FKK6 demonstrates for the first time that microbial metabolite mimicry is a viable strategy for drug discovery and opens the door to underexploited regions of chemical space.
Authors’ abstract
Abstract
The human PXR (pregnane X receptor), a master regulator of drug metabolism, has essential roles in intestinal homeostasis and abrogating inflammation. Existing PXR ligands have substantial off‐target toxicity. Based on prior work that established microbial (indole) metabolites as PXR ligands, we proposed microbial metabolite mimicry as a novel strategy for drug discovery that allows exploiting previously unexplored parts of chemical space. Here, we report functionalized indole derivatives as first‐in‐class non‐cytotoxic PXR agonists as a proof of concept for microbial metabolite mimicry.
The lead compound, FKK6 (Felix Kopp Kortagere 6), binds directly to PXR protein in solution, induces PXR‐specific target gene expression in cells, human organoids, and mice. FKK6 significantly represses pro‐inflammatory cytokine production cells and abrogates inflammation in mice expressing the human PXR gene. The development of FKK6 demonstrates for the first time that microbial metabolite mimicry is a viable strategy for drug discovery and opens the door to underexploited regions of chemical space.
Publication and source details
Original title: Targeting the pregnane X receptor using microbial metabolite mimicry
Zdeněk Dvořák; Felix Kopp; Cait M Costello; Jazmin S Kemp; Hao Li; Aneta Vrzalová; Martina Štěpánková; Iveta Bartoňková; Eva Jiskrová; Karolína Poulíková; Barbora Vyhlídalová; Lars U Nordstroem; Chamini V Karunaratne; Harmit S Ranhotra; Kyu Shik Mun; Anjaparavanda P Naren; Iain A Murray; Gary H Perdew; Julius Brtko; Lucia Toporova; Arne Schön; Bret D Wallace; William G Walton; Matthew R Redinbo; Katherine Sun; Amanda Beck; Sandhya Kortagere; Michelle C Neary; Aneesh Chandran; Saraswathi Vishveshwara; Maria M Cavalluzzi; Giovanni Lentini; Julia Yue Cui; Haiwei Gu; John C March; Shirshendu Chatterjee; Adam Matson; Dennis Wright; Kyle L Flannigan; Simon A Hirota; Ryan Balfour Sartor; Sridhar Mani
EMBO Molecular Medicine · 2020
* Corresponding author. Tel: +420 585634903; E‐mail: moulin@email.czCorresponding author. Tel: +1 215 991 8135; Fax: +1 215 848 2271; E‐mail: sandhya.kortagere@drexelmed.edu
Corresponding author. Tel: +1 718 430 2871; Fax: +1 718 430 8550; E‐mail: sridhar.mani@einstein.yu.edu
These authors contributed equally to this work
Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-12T17:58:14.052519+00:00
DOI: 10.15252/emmm.201911621 · PMC7136958